Here we show that concomitant immunoexpression of EGFR and TATI is an independent prognostic factor for favorable survival in colorectal cancer, and it is a stronger prognostic factor than EGFR or TATI/SPINK1 alone. The gene discussed is EGFR; the disease is colorectal cancer.